The WHO Global Code of Practice on the International Recruitment of Health Personnel was adopted on May 21, 2010. The Code "aims to establish and promote voluntary principles and practices for the ethical international recruitment of health personnel and to facilitate the strengthening of health systems."

Peter Navario discusses the looming resurgence of an HIV epidemic in Zimbabwe.

The rise of global health issues within the world of foreign policy is precipitating great interest in the concept and practice of health diplomacy. Much discussion of this new field, particularly within the global health community, has narrowly focused on how diplomatic negotiations and foreign policy can be used to support global health goals. Recent articles claim, for example, that "foreign policy is now being driven substantially by health," and that health can move "foreign policy away from a debate about interests to one about global altruism."

The Economist tells why so little is known about the effects of erupting volcanoes on air travel and their potential long-term effects.

An e-newsletter produced by CFR's Global Health Program looking at the Obama administration's Global Health Initiative, the swine flu backlash, and the dangers ahead for Haiti, as well as a number of other timely issues.

The global fight against HIV and AIDS cannot be won without success in South Africa, but while President Zuma's government has made progress, it has to do more to prevent future infections and provide better treatment, says CFR's Peter Navario.

In this Foreign Policy op-ed, Eduardo Gomez looks at President Barack Obama's new vision for tackling global health challenges,  examining how Obama's new initiative differs from the previous administration's approach by focusing on broad-category initiatives. 

Andrew Witty, Chief Executive Officer of Glaxosmithkline, speaks about innovative and economically sustainable new ways to ensure pharmaceutical access to populations in the developing world. This meeting is part of the CEO speaker series which aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.

Watch GlaxoSmithKline CEO Andrew Witty discuss steps GSK is taking to address neglected tropical diseases and to ensure access to vaccines in the developing world.

This session was part of the Corporate Program's CEO Speaker series.

Listen to GlaxoSmithKline CEO Andrew Witty discuss steps GSK is taking to address neglected tropical diseases and to ensure access to vaccines in the developing world.

This session was part of the Corporate Program's CEO Speaker series.

CFR's Peter Navario says a new patent pool giving generic drugmakers access to branded drugs to help lower costs of HIV-AIDS treatments in developing countries is timely and necessary, but more still needs to be accomplished.

Peter Navario and Scott Rosenstein discuss how enhancement of global vaccine access to low and middle-income countries is in the interests of the United States.

Laurie Garrett and Dana March point out that vaccinations against influenza do not mrerely protect the population from the virus itself but that they have significant long term health benefits that should not be ignored.